Research into Influenza spans multiple therapeutic approaches and trial phases.

18 total trials for this combination

Showing top 10 of 18 trials

Trials

NCT ID	Title	Status	Phase
NCT05608005	Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older	COMPLETED	PHASE1/PHASE2
NCT05375838	A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old	COMPLETED	PHASE1/PHASE2
NCT05827926	A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults	COMPLETED	PHASE1/PHASE2
NCT03282240	Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US	COMPLETED	PHASE3
NCT03301051	Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults	COMPLETED	PHASE3
NCT01992094	Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older	COMPLETED	PHASE3
NCT06508320	A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)	COMPLETED	PHASE2
NCT05585632	A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old	COMPLETED	PHASE1
NCT01224795	A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.	TERMINATED	PHASE3
NCT06097273	A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age	COMPLETED	PHASE3

Related Pages

All Influenza trials All trials in Hollywood, United States